Skip to main content
TipRanks
Go Ultimate75% OFF

Neuphoria Therapeutics (B1N0) Q4 2022 Earnings Report

2 Followers

DE:B1N0 Q4 2022 EPS Results

Actual EPS
-EUR 12.15
Consensus EPS
-EUR 1,023.96
Beat/Miss
Beat by +EUR 1,011.81
One Year Ago EPS
-EUR 0.01

DE:B1N0 Q4 2022 Revenue Results

Actual Revenue
EUR 166.35K
Expected Revenue
EUR 254.59K
Beat/Miss
Missed by -EUR 88.24K
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q4 2022
Date
08/25/2022
Time
Before Open
Conference Call
Thursday, August 25, 2022

Q4 2022 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:B1N0 Earnings History

DE:B1N0 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Sep 29, 20252025 (Q4)-1.82-2.31-25.6491.00% (+23.33)
Feb 20, 20252025 (Q2)―-――
Aug 21, 20242024 (Q4)-0.83-0.83-0.9310.23% (+0.09)
Feb 22, 20242024 (Q2)―-0.93-1.2928.10% (+0.36)
Aug 23, 20232023 (Q4)-0.98--1.01―
Feb 23, 20232023 (Q2)-7.00-15.49-5.37-188.32% (-10.12)
Aug 25, 20222022 (Q4)―-12.15-0.01-153677.78% (-12.14)
Feb 22, 20222022 (Q2)-10.79-5.370―
Aug 25, 20212021 (Q4)0.00-0.010―
Feb 26, 20212021 (Q2)0.000.00-0.98100.00% (+0.98)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed